Economist, Centennial Asia Advisors

Nicholas Chia

Centennial Asia Advisors deliver timely and accurate economic and political analysis to investors, focused on anticipating key turning points that affect the client’s interests in the Asia-Pacific region. Clients include public agencies and central banks, as well as fund managers and investment banks. The company draws strength from its flexibility to tailor products to fit client’s specific interests. It provides detailed macro-economic forecasts, scenario analysis and timely assessments of how specific major economic and political developments may affect a client’s areas of interest. At Centennial Asia Advisors, we tell it like it is. We have no vested interests, no need for a China wall, and no reason to skew our outlook any other way.

Economist

India: Recovery Looks Increasingly Tenuous But Modi Will Survive

Indian Economy: Monsoon Normalcy Bodes Well for Farm Incomes

India: Prices Could Surprise on the Upside

Indian Economy: Strong Growth Unlikely to Offset Fiscal Slippage Risks

Centennial Asia Advisors

At Centennial Asia Advisors, we tell it like it is. We have no vested interests, no need for a China wall, and no reason to skew our outlook any other way. With over 30 years experience covering Asia’s political economy, you can be sure our conclusions and analyses are based on the unadulterated facts. Through years of fine-tuning our research methodologies, we deliver a quality of macroeconomic analysis few other houses can match.

Centennial Asia Advisors is an independent research and advisory firm that works with governments, multilateral institutions, financial firms and leading MNCs.

Economic Policy and Strategic Advisors

Macroeconomics

<ul>
<li>A month ago, India was on track to register double-digits growth in FY22, aided by the much-vaunted claim that it has achieved herd immunity by design or by accident. That is now at risk.</li>
<li>What is clear is that India has not attained herd immunity, underscored by the soaring caseloads after bottoming out in early-February. Mutant strains and complacency could perhaps explain why cases started rising sharply, though there is still a lot to unpack about Covid-19.</li>
</ul>


A month ago, India was on track to register double-digits growth in FY22, aided by the much-vaunted claim that it has achieved herd immunity by design or by accident. That is now at risk.
What is clear is that India has not attained herd immunity, underscored by the soaring caseloads after bottoming out in early-February. Mutant strains and complacency could perhaps explain why cases started rising sharply, though there is still a lot to unpack about Covid-19.


India: Growth Narrative Risks Coming Undone